CytoDyn Inc. (CYDY) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$1.82M2012: -$4.39M2013: -$3.39M2014: -$7.39M2016: -$24.81M2017: -$26.73M2018: -$29.90M2019: -$50.47M2020: -$68.80M2021: -$117.57M2022: -$77.72M2023: -$25.11M2024: -$10.98M2025: -$8.77M-$8.77M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$8.77M+20.2%
2024-$10.98M+56.3%
2023-$25.11M+67.7%
2022-$77.72M+33.9%
2021-$117.57M-70.9%
2020-$68.80M-36.3%
2019-$50.47M-68.8%
2018-$29.90M-11.8%
2017-$26.73M-7.7%
2016-$24.81M
2014-$7.39M-117.7%
2013-$3.39M+22.7%
2012-$4.39M-141.1%
2011-$1.82M